Stimcell Energetics (STME) EBT Growth (3y) (2019 - 2024)
Stimcell Energetics (STME) EBT Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 17.92% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 12.67% |
| Feb 29, 2024 | 27.74% |
| Nov 30, 2023 | 31.62% |
| Aug 31, 2023 | 27.41% |
| May 31, 2023 | 31.94% |
| Feb 28, 2023 | 30.78% |
| Nov 30, 2022 | 22.22% |
| Aug 31, 2022 | 14.25% |
| May 31, 2022 | 48.55% |
| Feb 28, 2022 | -39.88% |
| Nov 30, 2021 | -50.95% |
| Aug 31, 2021 | -44.26% |
| May 31, 2020 | 16.18% |
| Feb 29, 2020 | -6.42% |
| Nov 30, 2019 | -7.07% |
| Aug 31, 2019 | 3.45% |
| May 31, 2019 | -53.64% |
| Feb 28, 2019 | 36.58% |